![Susanne Schultz-Hector](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Susanne Schultz-Hector
Direttore/Membro del Consiglio presso Virometix AG
Provenienza dei contatti di primo grado di Susanne Schultz-Hector
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Virometix AG
![]() Virometix AG Pharmaceuticals: MajorHealth Technology Virometix AG is a Swiss biotechnology company that focuses on developing vaccines and immunotherapeutic drugs for the prevention and treatment of infections and cancer. Virometix is based in Schlieren, CH. The private company's mission is to address the growing medical need for vaccines to combat infectious and chronic human diseases. The company was founded by John Anthony Robinson, and the CEO is Anna Sumeray.
4
| Private Company | Pharmaceuticals: Major | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Susanne Schultz-Hector tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
UBS Securities LLC
![]() UBS Securities LLC Investment ManagersFinance UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients. | Investment Managers | Director/Board Member | |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
![]() F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Medical SpecialtiesHealth Technology F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria. | Medical Specialties | Director/Board Member | |
AFFIMED N.V. | Biotechnology | Director of Finance/CFO | |
The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin | |
TVM Capital GmbH
![]() TVM Capital GmbH Investment ManagersFinance TVM Capital GmbH (TVMC) is an international venture capital firm headquartered in Munich, Germany. Founded in 1983, the firm was formerly known as Techno Venture Management. | Investment Managers | Private Equity Investor | |
University of Freiburg | College/University | Doctorate Degree Doctorate Degree | |
BLUEBIRD BIO, INC. | Biotechnology | Director/Board Member | |
NOXXON Pharma AG
![]() NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Biotechnology | Chairman | |
Horizon Therapeutics Switzerland GmbH
![]() Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Janssen Vaccines & Prevention BV
![]() Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Philipps University of Marburg | College/University | Doctorate Degree | |
Merck Research Laboratories Massachusetts LLC
![]() Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal | |
VIVORYON THERAPEUTICS N.V. | Biotechnology | Director/Board Member | |
EUROPEAN MEDICAL SOLUTIONS | Biotechnology | Director/Board Member | |
Ambu Innovation GmbH
![]() Ambu Innovation GmbH Medical SpecialtiesHealth Technology Ambu Innovation GmbH engages in the development and distribution of single-use and light-weight robotically-assisted high definition endoscopy products in the field of gastroenterology and gastro-intestinal surgery. Its products include invendoscope SC210, invendo ScopeController, and invendo SPU E210. The company was founded in 1992 and is headquartered in Kissing, Germany. | Medical Specialties | Director/Board Member | |
IMMUNE DESIGN CORP | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Etna Biotech SRL
![]() Etna Biotech SRL Miscellaneous Commercial ServicesCommercial Services Etna Biotech SRL provides bio-pharmaceutical research and develops vaccines. It engages in researching and developing vaccines and immunotherapeutics for infectious diseases and other chronic illnesses. The company was founded in 2001 and is headquartered in Catania, Italy. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Vakzine Projekt Management GmbH
![]() Vakzine Projekt Management GmbH Pharmaceuticals: MajorHealth Technology Vakzine Projekt Management GmbH develops vaccines and biopharmaceuticals products from laboratory stages through to clinical examination. It offers VPM2001 vaccine to prevent human cytomegalovirus infections and VPM5001 Soluferon vaccine, treatment for multiple sclerosis (MS) and hepatitis C. The company was founded in August 2002 and is headquartered in Hannover, Germany. | Pharmaceuticals: Major | General Counsel | |
BiognoSYS AG
![]() BiognoSYS AG Packaged SoftwareTechnology Services BiognoSYS AG operates as a biotechnology company. Its products include iRT Kit, HRM Kit, Sample Prep Kit, PlasmaDive, Spectronaut and SpectroDive. The company was founded by Philipp M. Antoni, Johan Malmstroem and Oliver Rinner on September 3, 2008 and is headquartered in Schlieren, Switzerland. | Packaged Software | Chairman | |
Novaremed AG
![]() Novaremed AG Pharmaceuticals: MajorHealth Technology Novaremed AG operates as a pharmaceutical company. It develops NEB74S, a molecule for the treatment of chronic pain. The company was founded by Eliahu Kaplan in 2008 and is headquartered in Petah Tikva, Israel. | Pharmaceuticals: Major | Chairman | |
Julius-Maximilians-Universität Würzburg | College/University | Doctorate Degree | |
ProteoMediX AG
![]() ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Biotechnology | Chairman Director/Board Member | |
BioSupport AG | Director/Board Member | ||
Anokion SA
![]() Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Medical/Nursing Services | Director/Board Member | |
Kanyos Bio, Inc.
![]() Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
MANTA Instruments, Inc.
![]() MANTA Instruments, Inc. Electronic Equipment/InstrumentsElectronic Technology MANTA Instruments, Inc., engages in the production of scientific instruments that characterize nanoparticles. It focuses on ViewSizer 3000 product which performs individual particle analysis simultaneously on particles ranging in size. The company was founded in 2014 and is headquartered in San Diego, CA. | Electronic Equipment/Instruments | Director/Board Member | |
Joint Polish Investment Fund Management BV
![]() Joint Polish Investment Fund Management BV Investment ManagersFinance Joint Polish Investment Fund Management BV (Joint Polish Investment Fund Management) is a venture capital firm founded in 2015. The firm headquartered in Netherlands. | Investment Managers | Private Equity Investor | |
Fondation De l'Hôpital Barrie Memorial
![]() Fondation De l'Hôpital Barrie Memorial Miscellaneous Commercial ServicesCommercial Services Fondation De l'Hôpital Barrie Memorial is a private company based in Ormstown, Canada. The Canadian company engages in raising funds to improve health care and services. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
KUROS BIOSCIENCES AG | Biotechnology | Director of Finance/CFO | |
HBM Fondation | Corporate Officer/Principal | ||
HealthUp Sp zoo
![]() HealthUp Sp zoo Packaged SoftwareTechnology Services HealthUp Sp zoo develops MySpiroo -a mobile spirometer, which is a handheld, portable, wireless, smartphone connected medical device. The company was founded on August 19, 2014 and is headquartered in Warsaw, Poland. | Packaged Software | Chairman | |
Kuros Biosciences AG
![]() Kuros Biosciences AG Miscellaneous Commercial ServicesCommercial Services Kuros Biosciences AG is a Swiss company that specializes in developing innovative solutions for targeted and controlled bone healing. The private company is based in Schlieren, Switzerland. The company's mission is to eliminate non-unions and improve patient rehabilitation. | Miscellaneous Commercial Services | Director/Board Member | |
Affimed GmbH
![]() Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Miscellaneous Commercial Services | Director/Board Member |
Statistiche
Distribuzione geografica
Svizzera | 14 |
Germania | 11 |
Stati Uniti | 10 |
Paesi Bassi | 3 |
Austria | 2 |
Settori
Health Technology | 21 |
Commercial Services | 7 |
Consumer Services | 5 |
Finance | 4 |
Technology Services | 3 |
Posizioni
Director/Board Member | 25 |
Corporate Officer/Principal | 7 |
Chairman | 6 |
Director of Finance/CFO | 5 |
Doctorate Degree | 4 |
Contatti più connessi
Insiders | |
---|---|
Harry Welten | 22 |
Axel Polack | 12 |
Jan Henrik ter Meulen | 9 |
Anna Sumeray | 2 |
- Borsa valori
- Insiders
- Susanne Schultz-Hector
- Connessioni Società